MESO
Mesoblast Ltd
Company Overview
| Mkt Cap | $2.14B | Price | $16.66 |
| Volume | 146.22K | Change | +1.40% |
| P/E Ratio | -24.4 | Open | $16.50 |
| Revenue | $5.9M | Prev Close | $16.43 |
| Net Income | $-88.0M | 52W Range | $8.34 - $22.00 |
| Div Yield | N/A | Target | $35.00 |
| Overall | 41 | Value | -- |
| Quality | 42 | Technical | 40 |
No chart data available
Stock Overview
Updated DailyMesoblast Ltd (MESO) is a leading Healthcare company in the Biotechnology industry, currently trading at $16.66 with a market capitalization of $2.14 billion. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows MESO with a volume of 146K shares. The stock opened up 0.43% from yesterday's close of $16.43. Current analyst estimates project earnings of $-0.3 per share for this year, with next year targeting $0.17.
MESO demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including NRC, NRSN, NTME, NWBO.
Key investment considerations for MESO include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 110.1%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MESO | $16.66 | +1.4% | 146.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |